Reports
Publicerat: 2018-11-21 10:05:28
STENOCARE A/S (“STENOCARE”) today announces its results for the period 2018-07-01 – 2018-09-30. The company"s first fiscal year has been extended to 2017-10-19 – 2018-12-31 and will hereafter be between the 1st of January until the 31st of December. Due to the formation of the company in October 2017, no comparative accounts are available. The report is available on www.stenocare.com.
Eleven months (October 19, 2017 – September 30, 2018) Fourth quarter (July 1 – September 30, 2018) Highlights during the period Highlights after the period For additional information regarding STENOCARE, please contact: STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot programme. The company was first to receive the Danish Medicines Agency"s permission to import, distribute as well as cultivate and produce medical cannabis. The company offers high quality pharmaceutical grade medical cannabis oil, which is produced by hygienic and high technology cultivation that comply with the strict Danish regulatory requirements. STENOCARE will also develop a separate production facility for the cultivation and production of medical cannabis at the company’s premises in Jutland, Denmark.
Thomas Skovlund Schnegelsberg, CEO
Phone: +45 31770060
E-mail: presse@stenocare.com